Ascelia Pharma — Major Shareholding Notification 2023

Dec 6, 2023

Issuer Ascelia Pharma AB

Holder

Niels Mengel

Instrument

Instrument Ordinary shares SE0010573113

Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	05/12/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,252,308
Directly held voting rights	180,263
Indirectly held voting rights	1,072,045
Percentage
Directly held shares	3.59124 %
Directly held voting rights	0.53223 %
Indirectly held voting rights	3.16526 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	3.69749 %	1,252,308
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	3.69749 %	1,252,308
Chain of controlling companies

total holdings Group
0	0	Øresund-Healthcare Management A/S
1,063,545 3.14016		Kibegeon ApS
8,500	0.0251	Kirsten Mengel
	Voting rights % Voting rights Company

Voting rights 1,252,308 Percentage of voting rights 3.6975

Notes (other relevant informations according to law)

"Anmälan till följd av att Öresund Healthcare Management A/S ("ÖHM") den 5 december 2023 delat ut samtliga sina aktier i Ascelia Pharma AB till sina aktieägare. Utdelningen har inneburit att ÖHM:s innehav i Ascelia Pharma AB underskrider 5 procent av såväl aktier som röster. Niels Mengel och Kirsten Mengel är närstående och utdelningen har också inneburit att deras gemensamma direkta och indirekta innehav underskrider 5 procent av såväl aktier som röster."

Published

06/12/2023 09:18

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25